Skip to main content
. 2022 Mar 23;227(4):488–497. doi: 10.1093/infdis/jiac108

Figure 1.

Figure 1.

Overall prevalence of anal and cervical human papillomavirus (HPV) infection in (A) human immunodeficiency virus (HIV)-negative women and (B) women with HIV. Error bar = 95% confidence interval. *Indicated HPV prevalence was statistically significantly different in the anus and the cervix using χ2 test. 2v-HPV, HPV16 and 18; 4v-HPV, HPV6, 11, 16, and 18; 9v-HPV, HPV6, 11, 16, 18, 31, 33, 45, 52, and 58; HR-HPV, high-risk HPV; HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68.